KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
75,830,993
Share change
+7,186,774
Total reported value
$1,042,439,039
Put/Call ratio
164%
Price per share
$13.75
Number of holders
138
Value change
+$89,791,074
Number of buys
71
Number of sells
59

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q3 2014

As of 30 Sep 2014, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,830,993 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, FMR LLC, Sectoral Asset Management Inc, Camber Capital Management LLC, OAK RIDGE INVESTMENTS LLC, State Street Corp, BlackRock Institutional Trust Company, N.A., and EAGLE ASSET MANAGEMENT INC. This page lists 138 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.